Overall Neuropathy Limitations Scale (ONLS)

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
onls total score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • No Disability0–0
  • Mild Disability1–3
  • Moderate Disability4–6
  • Severe Disability7–9
Direct Clinical Answer

The Overall Neuropathy Limitations Scale (ONLS) calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include arms grade. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Quantifies the severity of functional disability in peripheral neuropathy by assessing upper and lower extremity functional activities. This validated scale is widely used to track disease progression and treatment response in various neuropathic conditions, particularly immune-mediated polyneuropathies.

Clinical Indication

The Overall Neuropathy Limitations Scale (ONLS) is indicated for bedside clinical practice to support Quantifies the severity of functional disability in peripheral neuropathy by assessing upper and lower extremity functional activities. This validated scale is widely used to track disease progression and treatment response in various neuropathic conditions, particularly immune-mediated polyneuropathies.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.

Limitations & Contraindications

Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.

Clinical Pearls & Action Plan

Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility. Guideline pearl: Regular monitoring can help assess treatment response and disease progression.

Formula & Variables:

ONLS Total Score = Arms Grade (0-5) + Legs Grade (0-7)

Input Parameters

NameTypeRequiredDescription
arms_gradeintegerYesArms functional disability grade based on ability to perform arm and hand functions
legs_gradeintegerYesLegs functional disability grade based on walking ability, climbing stairs, and running capacity

Score Interpretation & Guidance

RangeStageDescription
0–0No DisabilityNo functional limitations
1–3Mild DisabilityMinimal functional limitations
4–6Moderate DisabilityModerate functional limitations
7–9Severe DisabilitySignificant functional limitations
10–12Very Severe DisabilityProfound functional limitations

Evidence-Based References (EBM)

  • Graham RC, Hughes RA. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry. 2006;77(8):973-6. doi: 10.1136/jnnp.2005.081547.DOI: 10.1136/jnnp.2005.081547
  • Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, et al. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol. 2008;7(2):136-44. doi: 10.1016/S1474-4422(07)70329-0.DOI: 10.1016/S1474-4422(07)70329-0
  • van Nes SI, Vanhoutte EK, van Doorn PA, Hermans M, Bakkers M, Kuitwaard K, et al. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies. Neurology. 2011;76(4):337-45. doi: 10.1212/WNL.0b013e318208824b.DOI: 10.1212/WNL.0b013e318208824b

Related calculators